Das hepatozelluläre Karzinom

citation_journal_title=Int J Cancer; citation_title=Estimating the world cancer burden: Globocan 2000; citation_author=DM Parkin, F Bray, J Ferlay, P Pisani; citation_volume=94; citation_publication_date=2001; citation_pages=153-156; citation_doi=10.1002/ijc.1440; citation_id=CR1 citation_journal_title=Semin Liver Dis; citation_title=Hepatocellular carcinoma and Hepatitis B virus; citation_author=HL-Y Chan, JJ-Y Sung; citation_volume=26; citation_publication_date=2006; citation_pages=153-161; citation_doi=10.1055/s-2006-939753; citation_id=CR2 citation_journal_title=Cancer Cell; citation_title=Focus on hepatocellular carcinoma; citation_author=J Bruix, L Boix, M Sala, JM Llovet; citation_volume=5; citation_publication_date=2004; citation_pages=215-219; citation_doi=10.1016/S1535-6108(04)00058-3; citation_id=CR3 citation_journal_title=Gastroenterology; citation_title=Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance; citation_author=A Sangiovanni, E Del Ninno, P Fasani, C De Fazio, G Ronchi, R Romeo, A Morabito, R de Franchis, M Colombo; citation_volume=126; citation_publication_date=2004; citation_pages=1005-1014; citation_doi=10.1053/j.gastro.2003.12.049; citation_id=CR4 citation_journal_title=Gastroenterology; citation_title=[alpha]-fetoprotein and ultrasonography screening for hepatocellular carcinoma; citation_author=B Daniele, A Bencivenga, AS Megna, V Tinessa; citation_volume=127; citation_publication_date=2004; citation_pages=S108-S112; citation_doi=10.1053/j.gastro.2004.09.023; citation_id=CR5 citation_journal_title=Liver Transpl; citation_title=The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma; citation_author=JM Llovet, J Fuster, J Bruix; citation_volume=10; citation_publication_date=2004; citation_pages=S115-S120; citation_doi=10.1002/lt.20034; citation_id=CR6 citation_journal_title=J Hepatol; citation_title=Novel advancements in the management of hepatocellular carcinoma in 2008; citation_author=JM Llovet, J Bruix; citation_volume=48; citation_publication_date=2008; citation_pages=S20-S37; citation_doi=10.1016/j.jhep.2008.01.022; citation_id=CR7 citation_journal_title=N Engl J Med; citation_title=Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis; citation_author=V Mazzaferro, E Regalia, R Doci, S Andreola, A Pulvirenti, F Bozzetti, F Montalto, M Ammatuna, A Morabito, L Gennari; citation_volume=334; citation_publication_date=1996; citation_pages=693-700; citation_doi=10.1056/NEJM199603143341104; citation_id=CR8 citation_journal_title=Liver Transpl; citation_title=Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome; citation_author=IW Graziadei, H Sandmueller, P Waldenberger, A Koenigsrainer, K Nachbaur, W Jaschke, R Margreiter, W Vogel; citation_volume=9; citation_publication_date=2003; citation_pages=557-563; citation_doi=10.1053/jlts.2003.50106; citation_id=CR9 citation_journal_title=Hepatology; citation_title=Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation; citation_author=DS Lu, NC Yu, SS Raman, C Lassman, MJ Tong, C Britten, F Durazo, S Saab, S Han, R Finn, JR Hiatt, RW Busuttil; citation_volume=41; citation_publication_date=2005; citation_pages=1130-1137; citation_doi=10.1002/hep.20688; citation_id=CR10 citation_journal_title=Gut; citation_title=Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less; citation_author=SM Lin, CJ Lin, CC Lin, CW Hsu, YC Chen; citation_volume=54; citation_publication_date=2005; citation_pages=1151-1156; citation_doi=10.1136/gut.2004.045203; citation_id=CR11 citation_journal_title=The Lancet; citation_title=Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial; citation_author=JM Llovet, MI Real, X Montana, R Planas, S Coll, J Aponte, C Ayuso, M Sala, J Muchart, R Sola; citation_volume=359; citation_publication_date=2002; citation_pages=1734-1739; citation_doi=10.1016/S0140-6736(02)08649-X; citation_id=CR12 citation_journal_title=Hepatology; citation_title=Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival; citation_author=JM Llovet, J Bruix; citation_volume=37; citation_publication_date=2003; citation_pages=429-442; citation_doi=10.1053/jhep.2003.50047; citation_id=CR13 citation_journal_title=JAMA; citation_title=Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial; citation_author=Cheng Bao-Quan, Jia Chong-Qi, Liu Chun-Tao, Fan Wei, Wang Qing-Liang, Zhang Zong-Li, Yi Cui-Hua; citation_volume=299; citation_issue=14; citation_publication_date=2008; citation_pages=1669-1674; citation_doi=10.1001/jama.299.14.1669; citation_id=CR14 citation_journal_title=N Engl J Med; citation_title=Sorafenib in advanced hepatocellular carcinoma; citation_author=JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, AC de Oliveira, A Santoro, JL Raoul, A Forner, M Schwartz, C Porta, S Zeuzem, L Bolondi, TF Greten, PR Galle, JF Seitz, I Borbath, D Haussinger, T Giannaris, M Shan, M Moscovici, D Voliotis, J Bruix; citation_volume=359; citation_publication_date=2008; citation_pages=378-390; citation_doi=10.1056/NEJMoa0708857; citation_id=CR15 Pinter M, Sieghart W, Graziadei IW, Vogel W, Maieron A, Königsmann R, Weissmann A, Kornek G, Plank C, Peck-Radosavljevic M (2009) Sorafenib in advanced hepatocellular carcinoma and advanced liver cirrhosis. Oncologist [Epub ahead of print] citation_journal_title=J Clin Oncol; citation_title=Is sorafenib (S) safe and effective in patients (pts) with hepatocellular carcinoma (HCC) and Child-Pugh B (CPB) cirrhosis? Abstract; citation_author=GK Abou-Alfa, D Amadori, A Santoro, A Figer, J De Greve, C Lathia, D Voliotis, S Anderson, M Moscovici, S Ricci; citation_volume=26; citation_issue=Suppl; citation_publication_date=2008; citation_pages=4518; citation_id=CR17 citation_journal_title=J Clin Oncol; citation_title=Phase II Study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer; citation_author=PA Philip, MR Mahoney, C Allmer, J Thomas, HC Pitot, G Kim, RC Donehower, T Fitch, J Picus, C Erlichman; citation_volume=23; citation_publication_date=2005; citation_pages=6657-6663; citation_doi=10.1200/JCO.2005.14.696; citation_id=CR18 citation_journal_title=Transplantation; citation_title=Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation; citation_author=W Sieghart, T Fuereder, K Schmid, D Cejka, J Werzowa, F Wrba, X Wang, D Gruber, S Rasoul-Rockenschaub, M Peck-Radosavljevic, V Wacheck; citation_volume=83; citation_publication_date=2007; citation_pages=425-432; citation_doi=10.1097/01.tp.0000252780.42104.95; citation_id=CR19 citation_journal_title=J Hepatol; citation_title=Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma; citation_author=D Semela, AC Piguet, M Kolev, K Schmitter, R Hlushchuk, V Djonov, C Stoupis, JF Dufour; citation_volume=46; citation_publication_date=2007; citation_pages=840-848; citation_doi=10.1016/j.jhep.2006.11.021; citation_id=CR20 citation_journal_title=J Clin Oncol; citation_title=Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma; citation_author=AB Siegel, EI Cohen, A Ocean, D Lehrer, A Goldenberg, JJ Knox, H Chen, S Clark-Garvey, A Weinberg, J Mandeli, P Christos, M Mazumdar, E Popa, RSJ Brown, S Rafii, JD Schwartz; citation_volume=26; citation_publication_date=2008; citation_pages=2992-2998; citation_doi=10.1200/JCO.2007.15.9947; citation_id=CR21 citation_journal_title=Hepatology; citation_title=Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?; citation_author=T Livraghi, F Meloni, M Di Stasi, E Rolle, L Solbiati, C Tinelli, S Rossi; citation_volume=47; citation_publication_date=2008; citation_pages=82-89; citation_doi=10.1002/hep.21933; citation_id=CR22 citation_journal_title=Ann Surg; citation_title=A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma; citation_author=MS Chen, JQ Li, Y Zheng, RP Guo, HH Liang, YQ Zhang, XJ Lin, WY Lau; citation_volume=243; citation_issue=3; citation_publication_date=2006; citation_pages=321-328; citation_doi=10.1097/01.sla.0000201480.65519.b8; citation_id=CR23 Chen A, Kang Y, Chen Z, Tsao C, Qin S, Kim J, Burock K, Zou J, Voliotis D, Guan ZZ (2008) Randomized phase III trial of sorafenib versus placebo in Asian patients with advanced hepatocellular carcinoma. (Abstracts) J Clin Oncol [Suppl]: 4509